With over a 20% mortality rate, the H7N9 could be the new threat that globalist opportunists will be sure to extort.
KUNMING, CHINA – APRIL 10: (CHINA OUT) A technician conducts tests for the H7N9 bird flu virus at the Kunming Center for Disease Control (CDC) on April 10, 2013 in Kunming, China. As of yesterday, China has confirmed five new cases of H7N9 in Shaoxing, Jiangsu and Shanghai. So far, China has reported 33 H7N9 bird flu cases, including nine deaths. (Photo by ChinaFotoPress/Getty Images)
by Shepard Ambellas
An investigation by Chinese authorities is ongoing. Many of the people infected with H7N9 are reported to have had contact with poultry. However some cases reportedly have not had such contact. Close contacts of confirmed H7N9 patients are being followed to determine whether any human-to-human spread of H7N9 is occurring. No sustained person-to-person spread of the H7N9 virus has been found at this time.
Human infections with avian influenza (AI, or “bird flu”) are rare but do occur, most commonly after exposure to infected poultry (Bird-to-human spread). Limited person-to-person spread of bird flu is thought to have occurred rarely in the past, most notably with avian influenza A (H5N1). Based on this previous experience, some limited human-to-human spread of this H7N9 virus would not be surprising. Most important, however, is that this transmission not be sustained (ongoing). Influenza viruses constantly change and it’s possible that this virus could become able to easily and sustainably spread between people, triggering a pandemic. CDC is following this situation closely and coordinating with domestic and international partners. CDC takes routine preparedness actions whenever a new virus with pandemic potential is identified, including developing a candidate vaccine virus to make a vaccine if it were to be needed. CDC also has issued guidance to clinicians and public health authorities in the United States, as well as provided information for people traveling to China. This is an evolving situation and there is still much to learn. CDC will provide updated information as it becomes available.” Treatment
According to officials and Wikipedia, “Currently, no vaccine exists for H7N9, but antigenic and genome sequencing suggests that H7N9 is sensitive to neuraminidase inhibitors, such as oseltamivir and zanamivir.
The Centers for Disease Control and Prevention (CDC) has begun sequencing and development of a vaccine as routine procedure for any new transgenic virus. The CDC and vaccine manufacturers are developing a candidate virus to be used in vaccine manufacturing if there is widespread transmission.
In response to a request from the United States Centers for Disease Control and Prevention (CDC) and Biomedical Advanced Research and Development Authority (BARDA), and after the H7N9 flu virus gene sequences were made available through the Global Initiative on Sharing All Influenza Data (GISAID), the J. Craig Venter Institute (JCVI) and Synthetic Genomics Vaccines, Inc. (SGVI) began working with Novartis to synthesize the genes of the new viral strain and supplied these synthesized genes to the CDC.” Sources: |